Skip to main content

Price Controls and Drug Affordability in India: Policy Options

  • Chapter
Impact of TRIPS in India
  • 166 Accesses

Abstract

Earlier work (Goddard et al. 2006) served to emphasise the significance of drug price controls that are an important policy instrument, because health systems cannot rely entirely on market mechanisms for healthcare delivery. Price controls are a method of regulating drug prices for achieving health policy goals (Gray & Matsebula 2003). The governments use interventions from the supply side by controlling drug prices and/or from the demand side by restricting reimbursements and by raising patient co-payments (Cai & Salmon 2005). From the manufacturers’ perspective, price controls restrict free market activity, limit profits, and restrict return on investment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Authors

Copyright information

© 2010 Prabodh Malhotra

About this chapter

Cite this chapter

Malhotra, P. (2010). Price Controls and Drug Affordability in India: Policy Options. In: Impact of TRIPS in India. Palgrave Macmillan, London. https://doi.org/10.1057/9780230290747_6

Download citation

Publish with us

Policies and ethics